The genotype distribution and allele frequencies in this study revealed no significant association between SLCO1B1 (rs4149117 and rs7311358) and the response to MTX treatment in patients with RA, contrasting with earlier findings. Here, SLCO1B1 is linked to rheumatoid arthritis.